Search

Search Results
Results 17481 - 17490 of 18774 for breast cancer
  • White Paper - 9 Oct 2025
    Enhance the accuracy and efficiency of your cytotoxicity assays with Incucyte’s real-time imaging platform.
  • Drug - 8 Oct 2025
    Consumer Medicine Information (CMI) about Onureg intended for persons living in Australia.
  • News - 23 Sep 2025
    A recurrent barrier to Medicare annual wellness visits, which provide preventative medicine guidance for older and disabled patients, occurs when patients introduce medical concerns to physicians...
  • Drug - 19 Sep 2025
    Consumer Medicine Information (CMI) about DBL Cisplatin Injection intended for persons living in Australia.
  • Drug - 18 Sep 2025
    Consumer Medicine Information (CMI) about Calquence tablets intended for persons living in Australia.
  • Drug - 16 Sep 2025
    Consumer Medicine Information (CMI) about Abstral sublingual tablets intended for persons living in Australia.
  • Drug - 4 Sep 2025
    Consumer Medicine Information (CMI) about Scemblix intended for persons living in Australia.
  • Drug - 6 Aug 2025
    Consumer Medicine Information (CMI) about Cosamide 50 intended for persons living in Australia.
  • News - 1 Aug 2025
    AI-based medicine will revolutionize care including for Alzheimer's and diabetes, predicts a technology expert, but it must be accessible to all patients.
  • Drug - 31 Jul 2025
    Consumer Medicine Information (CMI) about Spironolactone Viatris intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.